2 Manach, C, Williamson, G & Morand, C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, Suppl., 230S–242S.
3 Číž, M, Pavelková, M, Gallová, L, et al. (2008) The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW 264.7. Physiol Res 57, 393–402.
4 Dias, AS, Porawski, M, Alonso, M, et al. (2005) Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 135, 2299–2304.
5 Comalada, M, Camuesco, D, Sierra, S, et al. (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway. Eur J Immunol 35, 584–592.
6 Nair, MP, Mahajan, S, Reynolds, JL, et al. (2006) The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor α) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-κB system. Clin Vaccine Immunol 13, 319–328.
7 Vrijsen, R, Everaert, L & Boeyé, A (1988) Antiviral activity of flavones and potentiation by ascorbate. J Gen Virol 69, 1749–1751.
8 Chiang, LC, Chiang, W, Liu, MC, et al. (2003) In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. J Antimicrob Chemother 52, 194–198.
9 Chun, OK, Chung, SJ & Song, WO (2007) Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 137, 1244–1252.
10 Sampson, L, Rimm, E, Hollman, PCH, et al. (2002) Flavonol and flavone intakes in US health professionals. J Am Diet Assoc 102, 1414–1420.
11 de Boer, VCJ, Dihal, AA, van der Woude, H, et al. (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135, 1718–1725.
12 Harwood, M, Danielewska-Nikiel, B, Borzelleca, JF, et al. (2007) A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 45, 2179–2205.
13 Utesch, D, Feige, K, Dasenbrock, J, et al. (2008) Evaluation of the potential in vivo genotoxicity of quercetin. Mutat Res 654, 38–44.
14 Hertog, MGL, Feskens, EJM, Hollman, PCH, et al. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 1007–1011.
15 Neuhouser, ML (2004) Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50, 1–7.
16 Akbay, P, Basaran, AA, Undeger, U, et al. (2003) In vitro immunomodulatory activity of flavonoid glycosides from Urtica dioica L. Phytother Res 17, 34–37.
17 Oršolić, N & Bašić, I (2005) Water-soluble derivative of propolis and its polyphenolic compounds enhance tumoricidal activity of macrophages. J Ethnopharmacol 102, 37–45.
18 Yu, CS, Lai, KC & Yang, JS (2010) Quercetin inhibited murine leukemia WEHI-3 cells in vivo and promoted immune response. Phytother Res 24, 163–168.
19 Exon, JH, Magnuson, BA, South, EH, et al. (1998) Dietary quercetin, immune functions and colonic carcinogenesis in rats. Immunopharmacol Immunotoxicol 20, 173–190.
20 Bancroft, GJ (1993) The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 5, 503–510.
21 Cooper, MA, Fehniger, TA & Caligiuri, MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22, 633–640.
22 Kobayashi, SD, Voyich, JM, Burlak, C, et al. (2005) Neutrophils in the innate immune response. Arch Immunol Ther Exp 53, 505–517.
23 Henson, DA, Nieman, DC, Davis, JM, et al. (2008) Post-160-km race illness rates and decreases in granulocyte respiratory burst and salivary IgA output are not countered by quercetin ingestion. Int J Sports Med 29, 856–863.
24 Nieman, DC, Henson, DA, Gross, SJ, et al. (2007) Quercetin reduces illness but not immune perturbations after intensive exercise. Med Sci Sports Exerc 39, 1561–1569.
25 Koch, A, Kunkel, S & Strieter, R (1995) Cytokines in rheumatoid arthritis. J Invest Med 43, 28–38.
26 Danesh, J, Kaptoge, S, Mann, AG, et al. (2008) Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 5, e78.
27 Egert, S, Bosy-Westphal, A, Seiberl, J, et al. (2009) Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 102, 1065–1074.
28 Davis, JM, Murphy, EA, Carmichael, MD, et al. (2009) Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 296, R1071–R1077.
29 Nieman, DC, Henson, DA, Davis, JM, et al. (2007) Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol 103, 1728–1735.
30 Nieman, DC, Henson, DA, Davis, JM, et al. (2007) Quercetin ingestion does not alter cytokine changes in athletes competing in the Western States Endurance Run. J Interferon Cytokine Res 27, 1003–1012.
31 Nieman, DC, Henson, DA, Maxwell, KR, et al. (2009) Effects of quercetin and EGCG on mitochondrial biogenesis and immunity. Med Sci Sports Exerc 41, 1467–1475.
32 Chang, L, Gusewitch, GA, Chritton, DBW, et al. (1993) Rapid flow cytometric assay for the assessment of natural killer cell activity. J Immunol Methods 166, 45–54.
33 Bryant, J, Day, R, Whiteside, TL, et al. (1992) Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods 146, 91–103.
34 Perticarari, S, Presani, G & Banfi, E (1994) A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood. J Immunol Methods 170, 117–124.
35 Bastard, J-P, Jardel, C, Bruckert, E, et al. (2000) Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85, 3338–3342.
36 Rexrode, KM, Pradhan, A, Manson, JE, et al. (2003) Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol 13, 674–682.
37 Azzolina, A (2003) Substance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells. Biochim Biophys Acta 1643, 75–83.
38 Marquardt, D & Walker, L (2000) Dependence of mast cell IgE-mediated cytokine production on nuclear factor-κB activity. J Allergy Clin Immunol 105, 500–505.
39 Marques-Deak, A, Cizza, G, Eskandari, F, et al. (2006) Measurement of cytokines in sweat patches and plasma in healthy women: validation in a controlled study. J Immunol Methods 315, 99–109.
40 Nieman, DC, Henson, DA, Gusewitch, G, et al. (1993) Physical activity and immune function in elderly women. Med Sci Sports Exerc 25, 823–831.
41 Nieman, DC, Nehlsen-Cannarella, SL, Henson, DA, et al. (1996) Immune response to obesity and moderate weight loss. Int J Obesity 20, 353–360.
42 Graf, BA, Ameho, C, Dolnikowski, GG, et al. (2006) Rat gastrointestinal tissues metabolize quercetin. J Nutr 136, 39–44.
43 Nemeth, K & Piskula, MK (2007) Food content, processing, absorption and metabolism of onion flavonoids. Crit Rev Food Sci Nutr 47, 397–409.
44 Williamson, G, Barron, D, Shimoi, K, et al. (2005) In vitro biological properties of flavonoid conjugates found in vivo. Free Radical Res 39, 457–469.
45 Schoen, C, Schulz, A, Schweikart, J, et al. (2009) Regulatory effects of a fermented food concentrate on immune function parameters in healthy volunteers. Nutrition 25, 499–505.
46 Álvarez, P, Alvarado, C, Puerto, M, et al. (2006) Improvement of leukocyte functions in prematurely aging mice after five weeks of diet supplementation with polyphenol-rich cereals. Nutrition 22, 913–921.
47 Nieman, DC, Buckley, KS, Henson, DA, et al. (1995) Immune function in marathon runners versus sedentary controls. Med Sci Sports Exerc 27, 986–992.
48 Li, Q, Morimoto, K, Nakadai, A, et al. (2007) Healthy lifestyles are associated with higher levels of perforin, granulysin and granzymes A/B-expressing cells in peripheral blood lymphocytes. Prev Med 44, 117–123.